Most Recent

image: Things That Go Bump

Things That Go Bump

By | March 1, 2016

Scientists still don’t know why animals sleep or how to define the ubiquitous behavior.

2 Comments

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Microorganisms continually challenge our assumptions of what life can achieve.

1 Comment

image: Small Packages

Small Packages

By | August 1, 2014

When proverbs come true

0 Comments

image: Organelle Architecture

Organelle Architecture

By | December 1, 2013

There’s beauty in a cell’s marriage of structure and function.

1 Comment

image: A Chill Issue

A Chill Issue

By | February 1, 2013

The very cold, the merely chilled, and the colorful

0 Comments

image: In the Long Run

In the Long Run

By | December 1, 2012

Can emulating our early human ancestors make us healthier?

1 Comment

image: Avant-Garde Science

Avant-Garde Science

By | June 1, 2012

Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.

0 Comments

A Truly Happy Return

By | December 1, 2011

After a roller-coaster of an October, The Scientist resumes publication under new ownership.

12 Comments

image: A Shot in the Arm

A Shot in the Arm

By | June 1, 2011

Decades of vaccine research have expanded our understanding of the immune system and are yielding novel disease-fighting tactics.

0 Comments

image: The “Me Decade” of Cancer

The “Me Decade” of Cancer

By | April 1, 2011

Drugs that target specific tumors are harbingers of a new era of genetically informed medicine.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech